LexDanaLexDanabeta
Inventor

John A. Montgomery

Inventor
Birmingham, AL, US

Overview

59→
Patents
1978–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds34%
C07HSugars20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02PClimate change mitigation technologies in the production or processing of goods2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,486,148Ni(0) catalysts20198,178,510'Preparation of thioarabinofuranosyl compounds and use thereof'20127,838,508'4′-thio-L-xyloy furanosyl nucleosides, precursors thereof, preparation and use thereof'20107,691,820'Preparation of thioarabinofuranosyl compounds and use thereof'20107,470,784'Methods for synthesizing 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine'20087,148,223'4′-thio-L-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof'20067,138,385'Thioarabinofuranosyl compounds and use thereof'20066,949,640'Method for synthesizing 2-chloro-9-(2-fluoro-β-D-arabinofuranosyl)-9H-purin-6-amine'20056,914,061'4′-thio-L-xylofuranosyl nucleosides, precursors thereof, preparation and use thereof'20056,870,052'Preparation of thioarabinofuranosyl compounds and use thereof'20056,660,719'Inhibiting T-Cell proliferation'20036,656,915'Inhibiting T-cell proliferation'20036,576,621'Preparation of thioarabinofuranosyl compounds and use thereof'20036,562,861'Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors'20036,518,299'Substituted pyrrolidine compounds useful as neuraminidase inhibitors'20036,458,799'Deazaguanine analog, preparation thereof and use thereof'20026,410,594'Substituted cyclopentane compounds useful as neuraminidase inhibitors'20026,387,923'Imminoribitol PNP inhibitors, preparation thereof and use thereof'20026,248,577'Hypoxanthine-guanine phosphoribosyl transferase'20016,001,840'Methods of treatment of viral infections using carbocyclic deoxyguanosine analogs'19995,726,311'7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo›3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same'19985,721,240'9-substituted-8-unsubstituted-9-deazaguanines'19985,661,136'2-halo-2\'-fluoro ARA adenosines as antinoplastic agents'1997H0001631'Method of fabricating radar chaff'19975,591,722'2\'-deoxy-4\'-thioribonucleosides and their antiviral activity'19975,565,463'9-subtituted-8-unsubstituted-9-deazaguanines'19965,561,225'Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages'19965,478,928'2\',3\'-dideoxy-4\'-thioribonucleosides and synthetic precursors thereof'19955,384,310'2\'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions'19955,189,039'7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same'19935,128,458'2\',3\'-dideoxy-4\'-thioribonucleosides as antiviral agents'19925,102,873'Adenosine compounds useful in the prevention and treatment of vaccinia virus infections'19925,077,404'Cyclized 5,10-dideazaaminopterin compounds'19915,034,518'2-fluoro-9-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl) adenine nucleosides'19915,008,265'2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same'19915,008,270'2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same'19914,985,434'7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same'19914,985,433'2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same'19914,725,687'5-methyl-5-deaza analogues of methotrexate and N.sup.10 -ethylaminopterin'19884,645,840'Intermediates for preparing 1,2-dihydropyrido[3,4-b]-pyrazines'19874,628,089'Pyrido(2,3-D)pyrimidines'19864,600,716'1,2-dihydropyrido[3,4-b]pyrazines'19864,536,575'2-Amino-4(3H)-oxopyrido[2,3-d]pyrimidino'19854,526,964'2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine'19854,511,721'Intermediate for preparing antifungal 1,2-dihydropyrido[3,4-b]-pyrazines'19854,451,650'Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines'19844,450,160'1,2-Dihydropyrido[3,4-b]-pyrazines and method and intermediates for preparing same'19844,431,805'Pyrido[2,3-d]-pyrimidines'19844,387,228'Process for the production of (.+-.)3-deazaaristeromycin'19834,386,093'(.+-.)3-Deazaaristeromycin and uses'19834,357,324'Prodrug derivatives of 9.beta.-D-arabinofuranosyl-2-fluoroadenine'19824,210,745'Procedure for the preparation of 9-.beta.-D-arabinofuranosyl-2-fluoroadenine'19804,210,639'5\'-Deoxy-5\'-(isobutylthio)-3-deazaadenosine, method of making same and its antiviral effect on Rous sarcoma virus and Gross murine leukemia virus'19804,206,307'Preparation of tetrahydrofolic acid from folic acid'19804,188,378'Anticancer and antiviral activity of 9-.beta.-D-arabinofuranosyl-2-fluoroadenine'19804,172,200'Process for the preparation of 10-deazaaminopterin and related compounds'19794,148,999'Preparation and purification of citrovorum factor'19794,079,056'Method of making pteridine compounds'19784,077,957'6-(Bromomethyl)-2,4-diaminopteridine hydrobromide'1978

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1978–2012Based in Birmingham, AL, US· patent location history
1979–2012Patents assigned to SOUTHERN RES INST (32)· patent assignee history
1979–1983Patents assigned to US HEALTH (3)· patent assignee history
1980Patents assigned to U S OF AMERICA HEW SECRETARY (3)· patent assignee history
1991–1993Patents assigned to BIOCRYST INC (5)· patent assignee history
1996–2003Patents assigned to BIOCRYST PHARM INC (9)· patent assignee history
1997Based in Reston, VA, US· patent location history
2019Based in Ann Arbor, MI, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SOUTHERN RES INST321979–2012
BIOCRYST PHARM INC91996–2003
BIOCRYST INC51991–1993
U S OF AMERICA HEW SECRETARY31980
US HEALTH31979–1983
Locations
LocationPatentsSpan
Birmingham, AL, US571978–2012
Ann Arbor, MI, US12019
Reston, Virginia, US11997